Anti AMPAR autoimmune encephalitis
Evidence-based neurology checklist on anti ampar autoimmune encephalitis: Pathology The antibodies target AMPAR receptors They are made up of tetramers of the glutamate receptors (GluR) types 1, 2, 3 or 4 Epidemiology Clinical features Associated tumours Investigations Treatment Acronym
Pathology
- The antibodies target AMPAR receptors
- They are made up of tetramers of the glutamate receptors (GluR) types 1, 2, 3 or 4
Epidemiology
Clinical features
Associated tumours
Investigations
Treatment
Acronym
References
- Rosenfeld MR, Dalmau J. Anti-NMDA-receptor encephalitis and other synaptic autoimmune disorders. Curr Treat Options Neurol 2011; 13:324-332.
- Lee R, Buckley C, Irani SR, Vincent A. Autoantibody testing in encephalopathies. Pract Neurol 2012; 12:4-13.
- Vincent A, Bien CG, Irani SR, Waters P. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 2011; 10:759-772.
- Dogan Onugoren M, Deuretzbacher D, Haensch CA, et al. Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series. JNNP 2015; 86:965-972.
- Joubert B, Kerschen P, Zekeridou A, et al. Clinical spectrum of encephalitis associated with antibodies against the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor: case series and review of the literature. JAMA Neurol 2015; 72:1163-1169.
- And 3 more. Subscribe to see the full list
